Condition
Transplant, Kidney
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting1
Enrolling By Invitation1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06622187Phase 4Enrolling By Invitation
Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies
NCT06910527Recruiting
Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
NCT05610670Not ApplicableCompleted
Access to Parenthood and Gynecological Follow-up After Organ Transplantation
NCT03427008Not ApplicableWithdrawn
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients
NCT00187915Not ApplicableCompletedPrimary
Pilot Trial for Implementation of a MPA PK Monitoring Strategy
Showing all 5 trials